The crisis of resistant pathogens in respiratory tract infections--use of pharmacodynamic principles

Area of Science:

• Microbiology
• Infectious Diseases
• Pharmacology

Background:

• Increasing antibiotic resistance in key respiratory pathogens (Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis) poses a significant public health threat.
• Inappropriate antibiotic use, particularly for viral infections, is a major driver of multidrug resistance.
• Traditional methods for assessing antibiotic susceptibility, like minimum inhibitory concentration (MIC), have limitations.

Purpose of the Study:

• To introduce and explain the concept of pharmacokinetic/pharmacodynamic (PK/PD) breakpoints.
• To highlight the shift towards a more clinical approach in evaluating antimicrobial effectiveness.
• To inform about the basis of new outpatient respiratory tract infection management guidelines.

Main Methods:

• Review of traditional in vitro susceptibility testing (MIC determination).
• Explanation of the correlation between antimicrobial pharmacokinetics (PK), pharmacodynamics (PD), and MICs.
• Integration of clinical studies to establish PK/PD breakpoints.

Main Results:

• Development of a novel concept: PK/PD breakpoints.
• Establishment of a more clinically relevant method for evaluating antibiotic efficacy.
• Foundation for updated outpatient management guidelines.

Conclusions:

• Pharmacokinetic/pharmacodynamic (PK/PD) breakpoints represent a significant advancement in antimicrobial assessment.
• New guidelines for outpatient respiratory tract infection management are now based on PD parameters.
• This approach aims to optimize antibiotic use and combat rising resistance.